163 related articles for article (PubMed ID: 31742696)
1. Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent.
Overchuk M; Damen MPF; Harmatys KM; Pomper MG; Chen J; Zheng G
Photochem Photobiol; 2020 May; 96(3):718-724. PubMed ID: 31742696
[TBL] [Abstract][Full Text] [Related]
2. Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer.
Derks YHW; van Lith SAM; Amatdjais-Groenen HIV; Wouters LWM; Kip A; Franssen GM; Laverman P; Löwik DWPM; Heskamp S; Rijpkema M
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2425-2435. PubMed ID: 35029739
[TBL] [Abstract][Full Text] [Related]
3. Tuning Pharmacokinetics to Improve Tumor Accumulation of a Prostate-Specific Membrane Antigen-Targeted Phototheranostic Agent.
Harmatys KM; Overchuk M; Chen J; Ding L; Chen Y; Pomper MG; Zheng G
Bioconjug Chem; 2018 Nov; 29(11):3746-3756. PubMed ID: 30350576
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
Lütje S; Heskamp S; Franssen GM; Frielink C; Kip A; Hekman M; Fracasso G; Colombatti M; Herrmann K; Boerman OC; Gotthardt M; Rijpkema M
Theranostics; 2019; 9(10):2924-2938. PubMed ID: 31244933
[No Abstract] [Full Text] [Related]
5. Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors.
Ngen EJ; Chen Y; Azad BB; Boinapally S; Jacob D; Lisok A; Shen C; Hossain MS; Jin J; Bhujwalla ZM; Pomper MG; Banerjee SR
Nanotheranostics; 2021; 5(2):182-196. PubMed ID: 33564617
[TBL] [Abstract][Full Text] [Related]
6. Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand.
Derks YHW; Schilham MGM; Rijpkema M; Smeets EMM; Amatdjais-Groenen HIV; Kip A; van Lith SAM; van de Kamp J; Sedelaar JPM; Somford DM; Simons M; Laverman P; Gotthardt M; Löwik DWPM; Heskamp S; Lütje S
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2872-2884. PubMed ID: 37060367
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific membrane antigen (PSMA) targeted singlet oxygen delivery
Wang L; Tang L; Liu Y; Wu H; Liu Z; Li J; Pan Y; Akkaya EU
Chem Commun (Camb); 2022 Feb; 58(12):1902-1905. PubMed ID: 35029263
[TBL] [Abstract][Full Text] [Related]
8. Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen.
Wang X; Tsui B; Ramamurthy G; Zhang P; Meyers J; Kenney ME; Kiechle J; Ponsky L; Basilion JP
Mol Cancer Ther; 2016 Aug; 15(8):1834-44. PubMed ID: 27297866
[TBL] [Abstract][Full Text] [Related]
9. A PSMA-targeted theranostic agent for photodynamic therapy.
Chen Y; Chatterjee S; Lisok A; Minn I; Pullambhatla M; Wharram B; Wang Y; Jin J; Bhujwalla ZM; Nimmagadda S; Mease RC; Pomper MG
J Photochem Photobiol B; 2017 Feb; 167():111-116. PubMed ID: 28063300
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer.
Wang X; Ramamurthy G; Shirke AA; Walker E; Mangadlao J; Wang Z; Wang Y; Shan L; Schluchter MD; Dong Z; Brady-Kalnay SM; Walker NK; Gargesha M; MacLennan G; Luo D; Sun R; Scott B; Roy D; Li J; Basilion JP
Cancer Res; 2020 Jan; 80(2):156-162. PubMed ID: 31719100
[TBL] [Abstract][Full Text] [Related]
11. Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer.
Derks YHW; Rijpkema M; Amatdjais-Groenen HIV; Kip A; Franssen GM; Sedelaar JPM; Somford DM; Simons M; Laverman P; Gotthardt M; Löwik DWPM; Lütje S; Heskamp S
Theranostics; 2021; 11(4):1527-1541. PubMed ID: 33408764
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody.
Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
Mol Cancer Res; 2017 Sep; 15(9):1153-1162. PubMed ID: 28588059
[TBL] [Abstract][Full Text] [Related]
13. Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies?
Watanabe R; Hanaoka H; Sato K; Nagaya T; Harada T; Mitsunaga M; Kim I; Paik CH; Wu AM; Choyke PL; Kobayashi H
J Nucl Med; 2015 Jan; 56(1):140-4. PubMed ID: 25500827
[TBL] [Abstract][Full Text] [Related]
14. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.
Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a photodynamic therapy agent using a canine prostate cancer model.
Luo D; Wang X; Ramamurthy G; Walker E; Zhang L; Shirke A; Naidu NG; Burda C; Shakya R; Hostnik ET; Joseph M; Ponsky L; Ponomarev V; Rosol TJ; Tweedle MF; Basilion JP
Prostate; 2023 Sep; 83(12):1176-1185. PubMed ID: 37211857
[TBL] [Abstract][Full Text] [Related]
16. Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.
Chepurna OM; Yakovliev A; Ziniuk R; Nikolaeva OA; Levchenko SM; Xu H; Losytskyy MY; Bricks JL; Slominskii YL; Vretik LO; Qu J; Ohulchanskyy TY
J Nanobiotechnology; 2020 Jan; 18(1):19. PubMed ID: 31973717
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer.
Kularatne SA; Thomas M; Myers CH; Gagare P; Kanduluru AK; Crian CJ; Cichocki BN
Clin Cancer Res; 2019 Jan; 25(1):177-187. PubMed ID: 30201762
[TBL] [Abstract][Full Text] [Related]
18. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
19. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer.
Horn T; Krönke M; Rauscher I; Haller B; Robu S; Wester HJ; Schottelius M; van Leeuwen FWB; van der Poel HG; Heck M; Gschwend JE; Weber W; Eiber M; Maurer T
Eur Urol; 2019 Oct; 76(4):517-523. PubMed ID: 30987843
[TBL] [Abstract][Full Text] [Related]
20. Efficient Near-Infrared Photosensitizer with Aggregation-Induced Emission for Imaging-Guided Photodynamic Therapy in Multiple Xenograft Tumor Models.
Dai J; Li Y; Long Z; Jiang R; Zhuang Z; Wang Z; Zhao Z; Lou X; Xia F; Tang BZ
ACS Nano; 2020 Jan; 14(1):854-866. PubMed ID: 31820925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
